125 related articles for article (PubMed ID: 25075099)
1. A neutron dynamic therapy with a boron tracedrug UTX-51 using a compact neutron generator.
Hori H; Tada R; Uto Y; Nakata E; Morii T; Masuda K
Anticancer Res; 2014 Aug; 34(8):4557-60. PubMed ID: 25075099
[TBL] [Abstract][Full Text] [Related]
2. An NDT study of a boron tracedrug UTX-51 for glycated BSA as an AGE model.
Tada R; Uto Y; Masunaga S; Kinashi Y; Ono K; Hori H
Anticancer Res; 2014 Aug; 34(8):4503-7. PubMed ID: 25075093
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and destructive dynamic effects of BODIPY-containing and curcuminoid boron tracedrugs for neutron dynamic therapy.
Nakata E; Koizumi M; Yamashita Y; Onaka K; Sakurai Y; Kondo N; Ono K; Uto Y; Hori H
Anticancer Res; 2011 Jul; 31(7):2477-81. PubMed ID: 21873162
[TBL] [Abstract][Full Text] [Related]
4. Boron tracedrug design for neutron dynamic therapeutics for LDL.
Hori H; Nazumi Y; Uto Y
Adv Exp Med Biol; 2013; 789():385-389. PubMed ID: 23852519
[TBL] [Abstract][Full Text] [Related]
5. Molecular Interaction Between Boron Tracedrug UTX-51 Derivatives and Bovine Serum Albumin: Application to an Analytical Model of AGEs Destruction by Thermal Neutron Irradiation.
Ohkura K; Tabata A; Uto Y; Hori H
Anticancer Res; 2022 Aug; 42(8):4017-4023. PubMed ID: 35896254
[TBL] [Abstract][Full Text] [Related]
6. Boron tracedrugs challenge for neutron dynamic therapy.
Hori H; Uto Y; Nakata E
Anticancer Res; 2012 Jun; 32(6):2235-9. PubMed ID: 22641657
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight Into Protein Binding of Boron Tracedrug UTX-97 Revealed by the Co-Crystal Structure With Lysozyme at 1.26 Å Resolution.
Morimoto Y; Nagasawa H; Uto Y; Chatake T; Hori H
J Pharm Sci; 2016 Aug; 105(8):2298-301. PubMed ID: 27422088
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of sealed D-T neutron generator as neutron source for liver BNCT and its beam shaping assembly.
Liu Z; Li G; Liu L
Appl Radiat Isot; 2014 Apr; 86():1-6. PubMed ID: 24448270
[TBL] [Abstract][Full Text] [Related]
9. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
11. [Neutron capturing irradiation: principle, current results and perspectives].
Pignol JP; Chauvel P
Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
[TBL] [Abstract][Full Text] [Related]
12. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD-Functionalized
Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
[TBL] [Abstract][Full Text] [Related]
14. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
[TBL] [Abstract][Full Text] [Related]
15. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
16. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
17. Sensitizing effect of the phosphatidylinositol 3-kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound.
Kinashi Y; Sakurai Y; Masunaga S; Takagaki M; Ono K
Radiat Med; 2001; 19(1):27-32. PubMed ID: 11305615
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.
Mortensen MW; Sørensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
Appl Radiat Isot; 2006 Mar; 64(3):315-24. PubMed ID: 16290943
[TBL] [Abstract][Full Text] [Related]
19. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
20. Selective radiography of 10B distribution in organs using cold and thermal neutron beams.
Skvarc J; Giacomelli M; Yanagië H; Kühne G
Cell Mol Biol Lett; 2002; 7(1):162-4. PubMed ID: 11944078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
